Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SpotRx was a U.S. retail pharmacy brand operated by MedAvail that combined telepharmacy services, self-service prescription dispensing kiosks, mobile ordering, and home delivery. The business focused on improving medication access at the point of care through in-clinic pharmacy kiosks connected to live pharmacists. SpotRx served patients in several U.S. states including Arizona, California, Michigan, and Florida, and partnered with healthcare providers such as Cano Health and Cigna Medical Group. In January 2023, MedAvail announced the sale of certain SpotRx pharmacy assets to CVS Pharmacy as part of a strategic restructuring, and the SpotRx business appears to have ceased operating as an independent active pharmacy brand thereafter. SpotRx was not a drug-development biotech company; it was a commercial healthcare services and pharmacy access business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SpotRx.